CFDE Data Portal | Search HAPSTR2

	Label	Description
	HAPSTR2 Gene (Entity type)	ENSG00000230707 - HUWE1 associated protein modifying stress responses 2
	GSE153867 olaparib 6 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE165071,GSE165072 1 V 0 DEXAMETHASONE MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE104022 1 V 0 TAMOXIFEN MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE169617 azacitidine 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE258991 enzalutamide DK1 [Tursiops] 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE130437 palbociclib 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE137177 1 V 0 FOLIC ACID MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE226249 pirfenidone HL 2 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE128730 neratinib OVCAR-8 7 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS

HAPSTR2

ENSG00000230707 - HUWE1 associated protein modifying stress responses 2

GSE153867 olaparib 6 v 4 human dn

A Gene Set from LINCS

GSE165071,GSE165072 1 V 0 DEXAMETHASONE MOUSE UP

A Gene Set from LINCS

GSE104022 1 V 0 TAMOXIFEN MOUSE UP

A Gene Set from LINCS

GSE169617 azacitidine 1 v 2 human dn

A Gene Set from LINCS

GSE258991 enzalutamide DK1 [Tursiops] 1 v 0 human up

A Gene Set from LINCS

GSE130437 palbociclib 2 v 1 human dn

A Gene Set from LINCS

GSE137177 1 V 0 FOLIC ACID MOUSE DN

A Gene Set from LINCS

GSE226249 pirfenidone HL 2 v 7 human dn

A Gene Set from LINCS

GSE128730 neratinib OVCAR-8 7 v 2 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.